Table 1

Patients analyzeda

Patient characteristics

ABCoN (N = 98)

Nested I (N = 64)

Control (N = 102)


Mean (SD) age, years

54.8 (12.8)

52.6 (13.3)

55.9 (13.0)

Sex (female), n (%)

75 (78)b

53 (83)

77.4

Mean (SD) disease duration, years

10.3 (9.0)

9.2 (11.6)b

NA

Mean (SD) disease activity, DAS28 score

5.16 (0.95)

5.62 (0.91)

NA

RF-positive, n (%)

81 (87.1)

45 (70.3)b

NA

ACPA-positive, n (%)

75 (80.5)

37 (74.0)b

NA

Mean (SD) sG0/G1

1.37 (0.42)

1.38 (0.41)

1.02 (0.25)


a ABCoN, Autoimmune Biomarkers Collaborative Network; ACPA, Anti-Citrullinate Peptide Antibody; DAS28, 28-joint Disease Activity Score; RF, rheumatoid factor; sG0/G1, ratio of agalactosylated to monogalactosylated N-glycans in serum. bFractions represent proportions within available data. ABCoN gender data available in 96 patients; Nested I, disease duration available in 62 patients, RF in 63 and ACPA in 50 patients.

Ercan et al. Arthritis Research & Therapy 2012 14:R43   doi:10.1186/ar3756

Open Data